|
Avience Biomedicals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
136.03 Cr.
|
P/BV
|
6.19
|
Book Value (Rs.)
|
40.07
|
|
52 Week High/Low (Rs.)
|
415/222
|
FV/ML
|
10/600
|
P/E(X)
|
20.20
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 25.69 | 26.82 |
| Total Income From Operations | 25.69 | 26.82 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 2.18 | 3.44 |
| Purchase of Traded Goods | 14.70 | 12.29 |
| Increase/Decrease in Stocks | -3.68 | -0.09 |
| Employees Cost | 2.38 | 2.13 |
| Depreciation | 0.66 | 0.56 |
| Other Expenses | 2.42 | 1.80 |
| Total Expenses | 18.66 | 20.12 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 7.02 | 6.69 |
| Other Income | 0.23 | 0.06 |
| P/L Before Interest, Excpt. Items & Tax | 7.25 | 6.75 |
| Interest | 0.89 | 0.65 |
| P/L Before Exceptional Items & Tax | 6.37 | 6.10 |
| P/L Before Tax | 6.37 | 6.10 |
| Tax | 2.15 | 1.56 |
| P/L After Tax from Ordinary Activities | 4.22 | 4.54 |
| Net Profit/Loss For the Period | 4.22 | 4.54 |
| Net P/L After Minority Interest & Share Of Associates | 4.22 | 4.54 |
| | | |
| Equity Share Capital | 4.03 | 4.03 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 10.45 | 11.26 |
| Diluted EPS (Rs.) | 10.45 | 11.27 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 10.45 | 11.26 |
| Diluted EPS (Rs.) | 10.45 | 11.27 |
| | | |
| PBITOE Margin (%) | 27.33 | 24.96 |
| PBTE Margin (%) | 24.77 | 22.74 |
| PBT Margin (%) | 24.77 | 22.74 |
| PAT Margin (%) | 16.40 | 16.91 |
| PAT After MI And SOA Margin (%) | 16.40 | 16.91 |
